M&A Deal Summary |
|
|---|---|
| Date | 2024-10-25 |
| Target | Pyros Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Bora Pharmaceutical |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Piper Sandler & Co. (Financial) Cooley (Legal) |
SEARCH BY
Bora Pharmaceutical is focused on developing and manufacturing branded, generic, and over-the-counter (OTC) healthcare and pharmaceutical products for patients around the globe. Bora Pharmaceutical was founded in 2007 and is based in Taipei, Taiwan.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2024 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-17 |
Upsher-Smith Laboratories
Maple Grove, Minnesota, United States Upsher-Smith Laboratories is a pharmaceutical company, that delivers quality therapies and solutions that measurably improve individuals’ lives. Upsher-Smith Laboratories is based in Maple Grove, Minnesota. |
Buy | - |